• Fulvestrant (ICI 182,780): Protocols and Innovations in ER+

  2026-05-27

  Fulvestrant (ICI 182,780) is a premier tool for dissecting estrogen receptor signaling and overcoming endocrine resistance in breast cancer research. This article delivers actionable protocols, advanced troubleshooting strategies, and translational insights that leverage APExBIO’s trusted formulation for both in vitro and in vivo experimentation.

• Vasopressin Analogues: Multitasking Peptides and Lypressin A

  2026-05-27

  Glavaš et al. (2022) systematically review vasopressin and its analogues, emphasizing their evolution from natural hormones to multifunctional peptide therapeutics. The study highlights key advances in modifying vasopressin for improved pharmacological profiles, including the clinical and research relevance of lypressin acetate, with implications for disorders such as diabetes insipidus and emerging antiviral investigations.

• Phosphatase Inhibitor Cocktail 1: Precision in Phosphoproteo

  2026-05-26

  Phosphatase Inhibitor Cocktail 1 (100X in DMSO) preserves protein phosphorylation with unmatched fidelity, enabling robust analysis of dynamic signaling pathways. Its broad-spectrum inhibition empowers researchers to achieve accurate, reproducible results across workflows such as Western blotting, co-immunoprecipitation, and advanced phosphoproteomic studies.

• Scenario-Driven Best Practices with CP-673451 (SKU B2173)

  2026-05-26

  This article delivers an evidence-based, scenario-driven guide for researchers using CP-673451 (SKU B2173), a selective PDGFRα/β inhibitor. Through real-world laboratory questions, it clarifies protocol optimization, data interpretation, and vendor selection—anchored by robust literature and product data. Designed for biomedical scientists, it empowers reproducible cancer research and advanced angiogenesis assays.

• Risedronate Sodium for GIO in RA: Efficacy, Safety, and Rese

  2026-05-25

  The RISOTTO study provides robust evidence that Risedronate Sodium significantly increases lumbar spine bone mineral density in patients with glucocorticoid-induced osteoporosis (GIO) complicated by rheumatoid arthritis, with a favorable safety profile. This article analyzes the study's methodological rigor, places its findings in context with current research, and discusses implications for bone metabolism and translational workflows.

• Propidium Iodide: Precision DNA Intercalating Dye for Cell A

  2026-05-25

  Propidium iodide (PI) from APExBIO empowers researchers to precisely distinguish viable, apoptotic, and necrotic cells across cell viability, apoptosis, and cell cycle assays. This guide delivers actionable workflow enhancements, troubleshooting strategies, and critical insights for maximizing PI’s potential in quantitative cellular analysis.

• Vasopressin Analogues: Expanding Therapeutic and Research Ho

  2026-05-24

  The reference study provides a comprehensive review of vasopressin and its analogues, including lypressin acetate, highlighting their structural modifications, receptor selectivity, and evolving therapeutic applications. This synthesis clarifies the scientific rationale behind peptide analogues in treating diabetes insipidus and explores emerging antiviral potential, offering researchers a framework for experimental design and protocol optimization.

• Dabigatran in Translational Coagulation Research: From Mecha

  2026-05-23

  Explore the scientific foundation and translational value of Dabigatran as a direct thrombin inhibitor for stroke prevention and advanced coagulation research. This article uniquely dissects mechanistic insights, protocol precision, and clinical relevance beyond standard assay workflow guides.

• Blue Light Induces Skin Barrier Damage via EGFR/ERK/c-Jun Pa

  2026-05-22

  This article reviews a 2026 study demonstrating that repeated blue light irradiation impairs human and murine skin barrier integrity by activating the EGFR/ERK/c-Jun signaling cascade. The findings offer new mechanistic insights into how visible light contributes to skin barrier dysfunction, with implications for dermatological research and photoprotection strategies.

• Obacunone Induces Ferroptosis in Ovarian Cancer via Akt/p53

  2026-05-22

  This study reveals that obacunone, a natural citrus compound, induces ferroptosis and suppresses proliferation in ovarian cancer by modulating the Akt/p53 signaling pathway. Mechanistic dissection using the Akt activator SC 79 clarifies the regulatory cascade, providing a foundation for developing ferroptosis-based cancer therapies.

• Cell Counting Kit-8 Plus: Sensitive Tetrazolium Salt Assay W

  2026-05-21

  Cell Counting Kit-8 (CCK-8) Plus from APExBIO redefines the sensitivity and speed of tetrazolium salt assays for cell proliferation and cytotoxicity, integrating seamlessly into advanced air–liquid interface models and high-throughput screening. Its robust protocol and enhanced detection range empower researchers to generate rapid, reproducible data—even in challenging exposure and drug testing scenarios.

• Dual-Action Kinase Inhibition Alters p38α MAPK Dephosphoryla

  2026-05-21

  The referenced study demonstrates that certain kinase inhibitors can simultaneously block p38α MAP kinase activity and accelerate its dephosphorylation by the WIP1 phosphatase. This dual-action mechanism, revealed through structural and biochemical approaches, suggests a new avenue for designing highly specific inhibitors for inflammation and apoptosis research.

• Sulfo-Cy3 Azide: Advanced Bioconjugation Reagent for Click L

  2026-05-20

  Sulfo-Cy3 azide transforms aqueous-phase Click Chemistry, enabling high-brightness, photostable labeling of alkyne-modified biomolecules without organic solvents. This workflow-driven guide details best practices, troubleshooting, and insights from cutting-edge developmental neurobiology.

• Diethylmaleate in Oxidative Stress Models: From Mechanism to

  2026-05-20

  Explore how Diethylmaleate serves as a powerful tool for oxidative stress and redox regulation studies. This article details the compound’s biochemical mechanism, advanced assay design strategies, and practical insights distinct from standard resistance research.

• BCL-XL Inhibitor A-1155463: Precision Workflows in Cancer Re

  2026-05-19

  Discover how the selective BCL-XL inhibitor A-1155463 enables robust, reproducible induction of apoptosis in BCL-XL-dependent cancer models. This guide details optimized experimental workflows, troubleshooting strategies, and practical insights for translational oncology—bridging bench research with actionable protocols.

455 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page